Retinoic acid inhibits dendritic cell differentiation driven by interleukin-4
- 31 December 2009
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 259 (1) , 41-48
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Retinoic acid modulates chromatin to potentiate tumor necrosis factor alpha signaling on the DIF2 promoterNucleic Acids Research, 2007
- Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cellsBlood, 2004
- IL-4 alone without the involvement of GM-CSF transforms human peripheral blood monocytes to a CD1adim, CD83+ myeloid dendritic cell subsetJournal of Cell Science, 2004
- Retinoids Regulate Survival and Antigen Presentation by Immature Dendritic CellsJournal of Experimental Medicine, 2003
- Candida albicansIs Phagocytosed, Killed, and Processed for Antigen Presentation by Human Dendritic CellsInfection and Immunity, 2001
- The Common Vaccine Adjuvant Aluminum Hydroxide Up-Regulates Accessory Properties of Human Monocytes via an Interleukin-4-Dependent MechanismInfection and Immunity, 2001
- Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.Journal of Experimental Medicine, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.Journal of Experimental Medicine, 1994
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- Interleukin 4 down‐regulates the expression of CD14 in normal human monocytesEuropean Journal of Immunology, 1990